Breaking News Instant updates and real-time market news.

MS

Morgan Stanley

$74.13 /

-0.57 (-0.76%)

16:42
01/22/21
01/22
16:42
01/22/21
16:42

Morgan Stanley CFO sells 18.9K shares of common stock

In a regulatory filing, Morgan Stanley disclosed that its CFO Jonathan Pruzan sold 18.9K shares of common stock on January 22nd in a total transaction size of $1.41M, reducing his stake by about 7%.

  • 24

    Feb

MS Morgan Stanley
$74.13 /

-0.57 (-0.76%)

01/21/21 DA Davidson
Morgan Stanley price target raised to $90 from $80 at DA Davidson
01/21/21 Barclays
Morgan Stanley price target raised to $95 from $88 at Barclays
01/21/21 RBC Capital
Morgan Stanley price target raised to $78 from $55 at RBC Capital
01/20/21 BMO Capital
Morgan Stanley price target raised to $81 from $78 at BMO Capital

TODAY'S FREE FLY STORIES

General news
Asian Market Update: » 02:00
03/02/21
03/02
02:00
03/02/21
02:00

Asian Market Update: Risk…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
U.S. vehicle sales preview » 02:00
03/02/21
03/02
02:00
03/02/21
02:00

U.S. vehicle sales…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Treasury Market Summary » 22:25
03/01/21
03/01
22:25
03/01/21
22:25

Treasury Market Summary:…

Treasury Market Summary: March came in like a bull for Wall Street. The major indexes surged sharply higher on the back of more good news on vaccines and the expectation of massive stimulus sooner than later. Another batch of stronger than expected data helped too. But opening the door for the gains was the more subdued tenor of the Treasury market. The NASDAQ was up 3.01% with the S&P 500 2.38% firmer, with the Dow 1.95% higher. The risk-on flows lifted longer dated Treasury yields, but the cheapening was much more orderly than last week's furious 20 bps intraday jumps in the 10- and 30-year maturities. A heavy corporate calendar is also contributing to the losses in Treasuries with the focus on a $7 B 6-part deal from Goldman Sachs. The T-note was up 4 bps to 1.446% and the bond was 7 bps higher at 2.22%. The February ISM and the January construction spending strongly beat expectations and contributed to upward revisions in GDP projections. Analysts now expect a revision to Q4 GDP growth to 4.6% from 4.1%, and see a 4.8% clip for Q1. The Atlanta Fed boosted its Q1 projection to 10.04%. Meanwhile, Fedspeakers continued to show no fear over rising rates. View the summary.

Syndicate
Site Centers 15M share Spot Secondary priced at $13.20 » 21:12
03/01/21
03/01
21:12
03/01/21
21:12
SITC

Site Centers

$13.57 /

+0.22 (+1.65%)

Morgan Stanley and Wells…

Morgan Stanley and Wells Fargo are acting as joint book running managers for the offering.

ShowHide Related Items >><<
SITC Site Centers
$13.57 /

+0.22 (+1.65%)

SITC Site Centers
$13.57 /

+0.22 (+1.65%)

02/23/21 Mizuho
Site Centers price target raised to $13 from $10.50 at Mizuho
01/14/21 Piper Sandler
Site Centers upgraded to Overweight from Neutral at Piper Sandler
12/15/20 Citi
Site Centers price target raised to $11 from $8.50 at Citi
12/11/20 Truist
Site Centers price target raised to $10 from $7 at Truist
SITC Site Centers
$13.57 /

+0.22 (+1.65%)

  • 02
    Mar
Syndicate
WillScot Mobile Mini 12.75M share Spot Secondary priced at $27.20 » 21:11
03/01/21
03/01
21:11
03/01/21
21:11
WSC

WillScot Mobile Mini

$27.76 /

+0.05 (+0.18%)

The deal size was…

The deal size was increased to 12.75M shares from 10.75M and priced below the last closing price of $27.78. Morgan Stanley is acting as sole book running manager for the offering.

ShowHide Related Items >><<
WSC WillScot Mobile Mini
$27.76 /

+0.05 (+0.18%)

WSC WillScot Mobile Mini
$27.76 /

+0.05 (+0.18%)

02/02/21 Deutsche Bank
WillScot Mobile Mini price target raised to $26 from $22 at Deutsche Bank
01/26/21 DA Davidson
WillScot Mobile Mini price target raised to $30 from $25 at DA Davidson
01/13/21 Oppenheimer
WillScot Mobile Mini price target raised to $29 from $24 at Oppenheimer
11/10/20 Barclays
WillScot Mobile Mini reinstated with an Equal Weight at Barclays
WSC WillScot Mobile Mini
$27.76 /

+0.05 (+0.18%)

  • 02
    Mar
WSC WillScot Mobile Mini
$27.76 /

+0.05 (+0.18%)

Hot Stocks
SeaSpine sees 150-200bps of gross margin expansion in FY21 » 20:51
03/01/21
03/01
20:51
03/01/21
20:51
SPNE

SeaSpine

$20.42 /

+1.42 (+7.47%)

CEO Keith Valentine says:…

CEO Keith Valentine says: "Our priorities for 2021 are very similar to those, which I believe we have executed on very well in the past. Namely, to timely and effectively develop and launch clinically relevant products, to increase the number of core distributors and their exclusivity to SeaSpine, to generate above-market revenue growth through more efficient utilization of our spinal implant sets, and to further expand our gross margins. To that end, we plan to launch more than a dozen products in 2021, the most impactful being the alpha launches of the line extension of Mariner with an adult deformity indication and four additional 3D printed interbody systems and the migration of the many alpha launches we delivered in 2020 to full commercial launch. We expect to exit 2021, generating more than 75% of our U.S. Spinal Implant revenue from new and recently launched systems and more than 65% our U.S. revenue from existing and new core distributors. And we expect to generate between 150 to 250 basis points of gross margin expansion from more efficient utilization of our spinal implant sets and inventory and by gaining additional operating efficiencies from our Irvine manufacturing facility." Comments taken from Q4 earnings conference call transcript.

ShowHide Related Items >><<
SPNE SeaSpine
$20.42 /

+1.42 (+7.47%)

SPNE SeaSpine
$20.42 /

+1.42 (+7.47%)

03/01/21 Piper Sandler
SeaSpine price target raised to $28 from $22 at Piper Sandler
01/29/21 Piper Sandler
SeaSpine price target raised to $22 from $18 at Piper Sandler
01/11/21 Piper Sandler
SeaSpine should be bought on any weakness today, says Piper Sandler
10/19/20 Stifel
SeaSpine initiated with a Buy at Stifel
SPNE SeaSpine
$20.42 /

+1.42 (+7.47%)

SPNE SeaSpine
$20.42 /

+1.42 (+7.47%)

Recommendations
SeaSpine price target raised to $28 from $22 at Piper Sandler » 20:48
03/01/21
03/01
20:48
03/01/21
20:48
SPNE

SeaSpine

$20.42 /

+1.42 (+7.47%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien raised the firm's price target on SeaSpine to $28 from $22 and keeps an Overweight rating on the shares. The company's Q4 results were in line with its pre-announcement, and its initial guidance for FY21 was also "strong", the analyst tells investors in a research note. O'Brien adds that he remains impressed with SeaSpine's execution, and he sees building momentum in its business amid "significant" distributor wins, deeper account penetration, and double-digit new product launches annually.

ShowHide Related Items >><<
SPNE SeaSpine
$20.42 /

+1.42 (+7.47%)

SPNE SeaSpine
$20.42 /

+1.42 (+7.47%)

01/29/21 Piper Sandler
SeaSpine price target raised to $22 from $18 at Piper Sandler
01/11/21 Piper Sandler
SeaSpine should be bought on any weakness today, says Piper Sandler
10/19/20 Stifel
SeaSpine initiated with a Buy at Stifel
10/06/20 Piper Sandler
SeaSpine remains 'must-own SMID-cap name,' says Piper Sandler
SPNE SeaSpine
$20.42 /

+1.42 (+7.47%)

SPNE SeaSpine
$20.42 /

+1.42 (+7.47%)

Upgrade
Akamai upgraded to Overweight from Sector Weight at KeyBanc » 20:45
03/01/21
03/01
20:45
03/01/21
20:45
AKAM

Akamai

$95.92 /

+1.41 (+1.49%)

KeyBanc analyst Brandon…

KeyBanc analyst Brandon Nispel upgraded Akamai to Overweight from Sector Weight with a $119 price target.

ShowHide Related Items >><<
AKAM Akamai
$95.92 /

+1.41 (+1.49%)

AKAM Akamai
$95.92 /

+1.41 (+1.49%)

02/10/21
Fly Intel: Top five analyst downgrades
02/10/21 Craig-Hallum
Akamai downgraded to Hold at Craig-Hallum
02/10/21 Credit Suisse
Akamai price target raised to $115 from $105 at Credit Suisse
02/10/21 Craig-Hallum
Akamai downgraded to Hold from Buy at Craig-Hallum
AKAM Akamai
$95.92 /

+1.41 (+1.49%)

AKAM Akamai
$95.92 /

+1.41 (+1.49%)

AKAM Akamai
$95.92 /

+1.41 (+1.49%)

Earnings
Notable companies reporting before tomorrow's open » 20:25
03/01/21
03/01
20:25
03/01/21
20:25
TGT

Target

$186.12 /

+2.54 (+1.38%)

, AZO

AutoZone

$1,169.44 /

+9.2 (+0.79%)

, KSS

Kohl's

$56.95 /

+1.665 (+3.01%)

, ANF

Abercrombie & Fitch

$27.57 /

+0.05 (+0.18%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Target (TGT), consensus $2.54... AutoZone (AZO), consensus $12.84... Kohl's (KSS), consensus $1.01... Abercrombie & Fitch (ANF), consensus $1.21.

ShowHide Related Items >><<
TGT Target
$186.12 /

+2.54 (+1.38%)

KSS Kohl's
$56.95 /

+1.665 (+3.01%)

AZO AutoZone
$1,169.44 /

+9.2 (+0.79%)

ANF Abercrombie & Fitch
$27.57 /

+0.05 (+0.18%)

TGT Target
$186.12 /

+2.54 (+1.38%)

02/09/21 Jefferies
Dollar General well-positioned to mitigate minimum wage headwind, says Jefferies
02/08/21
Fly Intel: Top five analyst upgrades
02/08/21 Stifel
Target upgraded to Buy from Hold at Stifel
01/14/21 DA Davidson
Target price target raised to $229 from $208 at DA Davidson
AZO AutoZone
$1,169.44 /

+9.2 (+0.79%)

12/11/20
Fly Intel: Top five analyst upgrades
12/11/20 Jefferies
AutoZone upgraded to Buy on 'do-it-for-me' market share gains at Jefferies
12/11/20 Jefferies
AutoZone upgraded to Buy from Hold at Jefferies
10/14/20
Fly Intel: Top five analyst upgrades
KSS Kohl's
$56.95 /

+1.665 (+3.01%)

02/18/21 Morgan Stanley
Kohl's price target raised to $40 from $27 at Morgan Stanley
02/05/21 Baird
Kohl's price target raised to $58 from $48 at Baird
02/05/21 Deutsche Bank
Kohl's price target raised to $55 from $51 at Deutsche Bank
02/03/21
Fly Intel: Top five analyst upgrades
ANF Abercrombie & Fitch
$27.57 /

+0.05 (+0.18%)

02/16/21 JPMorgan
Abercrombie & Fitch price target raised to $27 from $26 at JPMorgan
01/14/21 JPMorgan
Abercrombie & Fitch price target raised to $26 from $24 at JPMorgan
12/30/20 B. Riley Securities
B. Riley checks show holiday outperformance for four retailers
12/01/20 Morgan Stanley
Abercrombie & Fitch price target raised to $14 from $10 at Morgan Stanley
TGT Target
$186.12 /

+2.54 (+1.38%)

KSS Kohl's
$56.95 /

+1.665 (+3.01%)

AZO AutoZone
$1,169.44 /

+9.2 (+0.79%)

ANF Abercrombie & Fitch
$27.57 /

+0.05 (+0.18%)

TGT Target
$186.12 /

+2.54 (+1.38%)

KSS Kohl's
$56.95 /

+1.665 (+3.01%)

TGT Target
$186.12 /

+2.54 (+1.38%)

KSS Kohl's
$56.95 /

+1.665 (+3.01%)

AZO AutoZone
$1,169.44 /

+9.2 (+0.79%)

TGT Target
$186.12 /

+2.54 (+1.38%)

KSS Kohl's
$56.95 /

+1.665 (+3.01%)

ANF Abercrombie & Fitch
$27.57 /

+0.05 (+0.18%)

Hot Stocks
EchoStar director buys 20K shares of common stock » 20:02
03/01/21
03/01
20:02
03/01/21
20:02
SATS

EchoStar

$23.22 /

+0.51 (+2.25%)

In a regulatory filing,…

In a regulatory filing, EchoStar disclosed that its Chief Strategy Officer Anders Johnson bought 20K shares of common stock on February 25th in a total transaction size of $469K, boosting his stake by 653%.

ShowHide Related Items >><<
SATS EchoStar
$23.22 /

+0.51 (+2.25%)

SATS EchoStar
$23.22 /

+0.51 (+2.25%)

01/25/21 Citi
EchoStar price target lowered to $27 from $30 at Citi
04/14/20 Citi
EchoStar price target lowered to $36 from $45 at Citi
SATS EchoStar
$23.22 /

+0.51 (+2.25%)

Upgrade
Atlantica Sustainable Infrastructure upgraded to Outperform at Raymond James » 19:58
03/01/21
03/01
19:58
03/01/21
19:58
AY

Atlantica Sustainable Infrastructure

$37.09 /

+0.915 (+2.53%)

Raymond James analyst…

Raymond James analyst David Quezada upgraded Atlantica Sustainable Infrastructure to Outperform from Market Perform with a $47 price target.

ShowHide Related Items >><<
AY Atlantica Sustainable Infrastructure
$37.09 /

+0.915 (+2.53%)

AY Atlantica Sustainable Infrastructure
$37.09 /

+0.915 (+2.53%)

01/27/21 Raymond James
Atlantica downgraded to Market Perform from Outperform at Raymond James
12/15/20 Seaport Global
Atlantica Yield upgraded to Buy after capital raise at Seaport Global
12/15/20 Seaport Global
Atlantica Yield upgraded to Buy from Neutral at Seaport Global
10/09/20 BofA
Atlantica Yield downgraded to Neutral from Buy at BofA
AY Atlantica Sustainable Infrastructure
$37.09 /

+0.915 (+2.53%)

  • 09
    Dec
Initiation
MP Materials initiated with an Overweight at Morgan Stanley » 19:57
03/01/21
03/01
19:57
03/01/21
19:57
MP

MP Materials

$46.26 /

+4.15 (+9.86%)

Morgan Stanley initiated…

Morgan Stanley initiated coverage of MP Materials with an Overweight rating and $57 price target.

ShowHide Related Items >><<
MP MP Materials
$46.26 /

+4.15 (+9.86%)

MP MP Materials
$46.26 /

+4.15 (+9.86%)

12/03/20
Fly Intel: Top five analyst initiations
12/03/20 Northland
MP Materials initiated with an Outperform at Northland
12/01/20 Deutsche Bank
MP Materials initiated with a Buy at Deutsche Bank
MP MP Materials
$46.26 /

+4.15 (+9.86%)

Hot Stocks
3D Systems sees FY21 gross margin 40%-44% » 19:54
03/01/21
03/01
19:54
03/01/21
19:54
DDD

3D Systems

$38.74 /

+2.89 (+8.06%)

The company "expects…

The company "expects 2021 gross profit margins to be between 40% and 44%, taking into account businesses divested in 2020 and early 2021, as well as the impact of the company's cost savings initiatives."

ShowHide Related Items >><<
DDD 3D Systems
$38.74 /

+2.89 (+8.06%)

DDD 3D Systems
$38.74 /

+2.89 (+8.06%)

01/29/21 Craig-Hallum
3D Systems downgraded to Hold from Buy at Craig-Hallum
01/29/21 Craig-Hallum
3D Systems downgraded to Hold from Buy at Craig-Hallum
01/25/21
Fly Intel: Top five analyst downgrades
01/25/21 Berenberg
3D Systems downgraded to Hold from Buy at Berenberg
DDD 3D Systems
$38.74 /

+2.89 (+8.06%)

DDD 3D Systems
$38.74 /

+2.89 (+8.06%)

DDD 3D Systems
$38.74 /

+2.89 (+8.06%)

Earnings
3D Systems reports Q4 EPS 9c, consensus 10c » 19:54
03/01/21
03/01
19:54
03/01/21
19:54
DDD

3D Systems

$38.74 /

+2.89 (+8.06%)

Reports Q4 revenue…

Reports Q4 revenue $172.7M, consensus $168.47M. 3D Systems announced that it will delay filing its Annual Report on Form 10-K for the fiscal year ended December 31, 2020. The company noted the "delay in filing is primarily related to the presentation of cash flows associated with the divestiture process for its Cimatron and GibbsCam software businesses. Based on preliminary analysis, the company believes that any financial impact resulting from this review is accounted for within its fourth quarter and full year 2020 results. The delayed filing has no impact on the operations of the company's business." CEO Dr. Jeff Graves commented "While we were greatly disappointed that we were not able to conclude the audit in a timely fashion, we are pleased to provide our preliminary financial results for the fourth quarter and full year 2020, and look forward to discussing these results and our progress in positioning 3D Systems for sustained profitable growth on our conference call tomorrow."

ShowHide Related Items >><<
DDD 3D Systems
$38.74 /

+2.89 (+8.06%)

DDD 3D Systems
$38.74 /

+2.89 (+8.06%)

01/29/21 Craig-Hallum
3D Systems downgraded to Hold from Buy at Craig-Hallum
01/29/21 Craig-Hallum
3D Systems downgraded to Hold from Buy at Craig-Hallum
01/25/21
Fly Intel: Top five analyst downgrades
01/25/21 Berenberg
3D Systems downgraded to Hold from Buy at Berenberg
DDD 3D Systems
$38.74 /

+2.89 (+8.06%)

DDD 3D Systems
$38.74 /

+2.89 (+8.06%)

DDD 3D Systems
$38.74 /

+2.89 (+8.06%)

On The Fly
Fly Intel: After-Hours Movers » 18:59
03/01/21
03/01
18:59
03/01/21
18:59
INO

Inovio

$11.64 /

+0.52 (+4.68%)

, ASLN

Aslan Pharmaceuticals

$5.22 /

+0.82 (+18.64%)

, TTEC

TTEC Holdings

$88.80 /

+4.49 (+5.33%)

, ZM

Zoom Video

$409.67 /

+35.805 (+9.58%)

, HLIO

Helios Technologies

$67.14 /

+1.295 (+1.97%)

, AMRC

Ameresco

$60.46 /

+3.18 (+5.55%)

, TMDX

TransMedics

$36.30 /

+0.33 (+0.92%)

, MREO

Mereo BioPharma

$3.96 /

+0.07 (+1.80%)

, ROKU

Roku

$420.23 /

+25.095 (+6.35%)

, NLSN

Nielsen

$23.15 /

+0.73 (+3.26%)

, FGEN

FibroGen

$50.35 /

+0.38 (+0.76%)

, AI

C3.ai

$120.78 /

+8.41 (+7.48%)

, INSG

Inseego

$15.00 /

+0.35 (+2.39%)

, LMND

Lemonade

$132.23 /

+6.5 (+5.17%)

, MORF

Morphic

$84.57 /

+48.64 (+135.37%)

, SCPL

SciPlay

$19.28 /

+1.07 (+5.88%)

, NIO

NIO

$49.79 /

+3.08 (+6.59%)

, SWCH

Switch

$17.69 /

+0.33 (+1.90%)

, NVAX

Novavax

$239.73 /

+8.52 (+3.68%)

, SRPT

Sarepta

$86.94 /

-0.07 (-0.08%)

, SILK

Silk Road Medical

$55.35 /

+0.53 (+0.97%)

, OSUR

OraSure

$11.08 /

+0.42 (+3.94%)

, APPF

AppFolio

$160.72 /

-4.985 (-3.01%)

, SGMS

Scientific Games

$50.79 /

+3.84 (+8.18%)

, MELI

MercadoLibre

$1,715.90 /

+80.81 (+4.94%)

, RDHL

RedHill Biopharma

$9.19 /

-0.33 (-3.47%)

, COHU

Cohu

$46.01 /

+2.46 (+5.65%)

, BYND

Beyond Meat

$147.09 /

+1.7 (+1.17%)

Check out this evening's…

ShowHide Related Items >><<
ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

TTEC TTEC Holdings
$88.80 /

+4.49 (+5.33%)

TMDX TransMedics
$36.30 /

+0.33 (+0.92%)

SWCH Switch
$17.69 /

+0.33 (+1.90%)

SRPT Sarepta
$86.94 /

-0.07 (-0.08%)

SILK Silk Road Medical
$55.35 /

+0.53 (+0.97%)

SGMS Scientific Games
$50.79 /

+3.84 (+8.18%)

SCPL SciPlay
$19.28 /

+1.07 (+5.88%)

ROKU Roku
$420.23 /

+25.095 (+6.35%)

RDHL RedHill Biopharma
$9.19 /

-0.33 (-3.47%)

OSUR OraSure
$11.08 /

+0.42 (+3.94%)

NVAX Novavax
$239.73 /

+8.52 (+3.68%)

NLSN Nielsen
$23.15 /

+0.73 (+3.26%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

MREO Mereo BioPharma
$3.96 /

+0.07 (+1.80%)

MORF Morphic
$84.57 /

+48.64 (+135.37%)

MELI MercadoLibre
$1,715.90 /

+80.81 (+4.94%)

LMND Lemonade
$132.23 /

+6.5 (+5.17%)

INSG Inseego
$15.00 /

+0.35 (+2.39%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

HLIO Helios Technologies
$67.14 /

+1.295 (+1.97%)

FGEN FibroGen
$50.35 /

+0.38 (+0.76%)

COHU Cohu
$46.01 /

+2.46 (+5.65%)

BYND Beyond Meat
$147.09 /

+1.7 (+1.17%)

ASLN Aslan Pharmaceuticals
$5.22 /

+0.82 (+18.64%)

APPF AppFolio
$160.72 /

-4.985 (-3.01%)

AMRC Ameresco
$60.46 /

+3.18 (+5.55%)

AI C3.ai
$120.78 /

+8.41 (+7.48%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

02/11/21 Oppenheimer
Opco starts DNA medicines 'disruptor' Inovio with buy, $35 price target
02/11/21 Oppenheimer
Inovio initiated with an Outperform at Oppenheimer
02/09/21 Maxim
Heat data puts cancer vaccine discussion 'back on the table,' says Maxim
01/08/21 Benchmark
Inovio price target lowered to $15 from $25 at Benchmark
ASLN Aslan Pharmaceuticals
$5.22 /

+0.82 (+18.64%)

03/01/21 Piper Sandler
Piper boosts Aslan target to $10 after positive atopic dematitis data
04/13/20 Piper Sandler
Aslan interim data for ASLN004 study still expected in 2020, says Piper Sandler
03/18/20 Piper Sandler
Aslan Pharmaceuticals price target lowered to $6 from $8 at Piper Sandler
TTEC TTEC Holdings
$88.80 /

+4.49 (+5.33%)

12/17/20 Canaccord
TTEC Holdings price target raised to $90 from $77 at Canaccord
10/15/20 Canaccord
TTEC Holdings model steadily shifts to digital, Canaccord starts with a Buy
10/15/20 Canaccord
TTEC Holdings initiated with a Buy at Canaccord
08/10/20
Fly Intel: Top five analyst downgrades
ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

01/26/21 MKM Partners
Fiverr downgraded to Sell from Neutral at MKM Partners
01/13/21 Stifel
Stifel says Zoom growth with Phone reminder of 'powerful' enterprise opportunity
01/13/21 Morgan Stanley
Investors have turned too negative on Zoom's persistence, says Morgan Stanley
12/24/20 DA Davidson
DA Davidson likes Zoom push into email, says buy on recent selloff
HLIO Helios Technologies
$67.14 /

+1.295 (+1.97%)

10/12/20 Baird
Helios Technologies upgraded to Outperform from Neutral at Baird
05/29/20 Morgan Stanley
Morgan Stanley upgrades Helios to Equal Weight following underperformance
05/29/20 Morgan Stanley
Helios Technologies upgraded to Equal Weight from Underweight at Morgan Stanley
03/27/20 Truist
Helios Technologies price target lowered to $36 from $45 at SunTrust
AMRC Ameresco
$60.46 /

+3.18 (+5.55%)

02/09/21 B. Riley Securities
Ameresco price target raised to $72 from $50 at B. Riley Securities
01/26/21 Craig-Hallum
Ameresco price target raised to $75 from $50 at Craig-Hallum
11/03/20 Craig-Hallum
Ameresco price target raised to $50 from $38 at Craig-Hallum
11/03/20 B. Riley Securities
Ameresco price target raised to $50 from $48 at B. Riley Securities
TMDX TransMedics
$36.30 /

+0.33 (+0.92%)

02/24/21 Cowen
TransMedics price target raised to $44 from $20 at Cowen
10/08/20
Fly Intel: Top five analyst downgrades
10/08/20 JPMorgan
TransMedics downgraded to Neutral on 'missed' execution at JPMorgan
10/08/20 JPMorgan
TransMedics downgraded to Neutral from Overweight at JPMorgan
MREO Mereo BioPharma
$3.96 /

+0.07 (+1.80%)

ROKU Roku
$420.23 /

+25.095 (+6.35%)

02/22/21 Needham
Roku price target raised to $550 from $400 at Needham
02/19/21 Truist
Roku price target raised to $480 from $390 at Truist
02/19/21 JPMorgan
Roku price target raised to $525 from $475 at JPMorgan
02/19/21 Oppenheimer
Roku price target raised to $500 from $260 at Oppenheimer
NLSN Nielsen
$23.15 /

+0.73 (+3.26%)

03/01/21 Truist
Nielsen price target raised to $26 from $20 at Truist
01/28/21 Citi
Nielsen price target raised to $27 from $22 at Citi
11/03/20 Deutsche Bank
Nielsen price target lowered to $18 from $22 at Deutsche Bank
08/25/20 Truist
Nielsen price target lowered to $20 from $23 at Truist
FGEN FibroGen
$50.35 /

+0.38 (+0.76%)

02/01/21 H.C. Wainwright
FibroGen initiated with a Buy at H.C. Wainwright
12/21/20 Mizuho
FibroGen should be bought on PDUFA extension weakness, says Mizuho
10/26/20 Raymond James
FibroGen initiated with an Underperform at Raymond James
10/26/20 Raymond James
FibroGen initiated with an Underperform at Raymond James
AI C3.ai
$120.78 /

+8.41 (+7.48%)

01/04/21 KeyBanc
C3.ai initiated with a Sector Weight at KeyBanc
01/04/21 Wedbush
Wedbush bullish on C3.ai, initiates with an Outperform
01/04/21 Canaccord
C3.ai initiated with a Hold at Canaccord
01/04/21 Morgan Stanley
C3.ai initiated with an Underweight at Morgan Stanley
INSG Inseego
$15.00 /

+0.35 (+2.39%)

02/17/21 Cowen
Inseego price target raised to $20 from $17 at Cowen
09/04/20 Stifel
Inseego 5G opportunity highlighted in meetings with management, says Stifel
08/06/20
Fly Intel: Top five analyst downgrades
08/06/20 Lake Street
Inseego price target raised to $17 from $13 at Lake Street
LMND Lemonade
$132.23 /

+6.5 (+5.17%)

01/21/21 Piper Sandler
Lemonade price target raised to $163 from $105 at Piper Sandler
11/23/20 Morgan Stanley
Root initiated with an Equal Weight at Morgan Stanley
11/12/20 Piper Sandler
Lemonade price target raised to $71 from $63 at Piper Sandler
11/02/20 Piper Sandler
Lemonade initiated with an Overweight at Piper Sandler
MORF Morphic
$84.57 /

+48.64 (+135.37%)

03/01/21 Wells Fargo
Morphic Holding price target raised to $103 from $40 at Wells Fargo
02/02/21 RBC Capital
Morphic Holding price target raised to $50 from $35 at RBC Capital
10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
08/11/20 BMO Capital
Morphic Holding price target raised to $37 from $30 at BMO Capital
SCPL SciPlay
$19.28 /

+1.07 (+5.88%)

02/18/21 Deutsche Bank
SciPlay price target raised to $23 from $20 at Deutsche Bank
02/17/21 BofA
SciPlay double-downgraded to Underperform from Buy at BofA
12/22/20 Morgan Stanley
SciPlay price target raised to $16 from $15 at Morgan Stanley
12/16/20 JPMorgan
SciPlay downgraded to Neutral on tough comps at JPMorgan
NIO NIO
$49.79 /

+3.08 (+6.59%)

02/26/21 HSBC
NIO price target raised to $54 from $44.70 at HSBC
02/09/21 Deutsche Bank
NIO job post shows ambitions to enter U.S. market, says Deutsche Bank
01/28/21 Morgan Stanley
NIO price target raised to $80 from $33 at Morgan Stanley
01/22/21
Fly Intel: Top five analyst initiations
SWCH Switch
$17.69 /

+0.33 (+1.90%)

02/02/21
Truist sees Switch positioned for long-term growth, starts at Buy
02/02/21 Truist
Switch initiated with a Buy at Truist
01/13/21 Jefferies
Switch upgraded to Buy on earnings growth inflection at Jefferies
01/13/21 Jefferies
Switch upgraded to Buy from Hold at Jefferies
NVAX Novavax
$239.73 /

+8.52 (+3.68%)

02/23/21 B. Riley Securities
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/22/21 Cantor Fitzgerald
Cantor says PREVENT-19 gives Novavax potential for differentiated analyses
02/22/21 B. Riley Securities
B. Riley reiterates Buy rating on Novavax as PREVENT-19 enrollment wraps up
02/18/21 B. Riley Securities
Novavax price target raised to $397 from $334 at B. Riley Securities
SRPT Sarepta
$86.94 /

-0.07 (-0.08%)

02/26/21 Mizuho
Sarepta price target raised to $160 from $158 at Mizuho
02/25/21 Piper Sandler
Piper says Sarepta's Amondys 45 approval comes with 'relatively clean label'
02/09/21 Morgan Stanley
Sarepta denied motion to dismiss 'Wilson Wolf' case, says Morgan Stanley
01/12/21 Citi
Sarepta downgraded to Neutral from Buy at Citi
SILK Silk Road Medical
$55.35 /

+0.53 (+0.97%)

02/04/21 Piper Sandler
Silk Road recall update 'should be received positively,' says Piper Sandler
01/25/21 Piper Sandler
Silk Road Medical recall primarily manufacturing related, says Piper Sandler
01/13/21 Piper Sandler
Piper Sandler sees no 'larger issue in play' following Silk Road Medical recall
11/11/20 Piper Sandler
Silk Road Medical price target raised to $58 from $54 at Piper Sandler
OSUR OraSure
$11.08 /

+0.42 (+3.94%)

12/22/20 Lake Street
Lake Street says OraSure test news disappointing, not due to fundamental issues
08/21/20
Fly Intel: Top five analyst initiations
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
08/21/20 Evercore ISI
OraSure initiated with an Outperform at Evercore ISI
APPF AppFolio
$160.72 /

-4.985 (-3.01%)

02/25/21 DA Davidson
AppFolio price target raised to $126 from $110 at DA Davidson
01/25/21 Stephens
AppFolio initiated with an Underweight at Stephens
01/25/21 Stephens
AppFolio initiated with an Underweight at Stephens
10/26/20 Keefe Bruyette
AppFolio initiated with a Market Perform at Keefe Bruyette
SGMS Scientific Games
$50.79 /

+3.84 (+8.18%)

02/09/21 Craig-Hallum
Scientific Games Digital segment still 'underappreciated,' says Craig-Hallum
01/19/21 Jefferies
Scientific Games price target raised to $55 from $50 at Jefferies
01/14/21 Truist
Scientific Games price target raised to $60 from $45 at Truist
01/14/21 Craig-Hallum
Dec. NJ gaming data caps off year of significant growth, says Craig-Hallum
MELI MercadoLibre
$1,715.90 /

+80.81 (+4.94%)

03/01/21 Credit Suisse
MercadoLibre price target raised to $1,925 from $1,555 at Credit Suisse
02/11/21
Fly Intel: Top five analyst initiations
02/11/21 Scotiabank
Scotiabank starts MercadoLibre at neutral, awaits better entry point
02/11/21 Scotiabank
MercadoLibre initiated with a Sector Perform at Scotiabank
RDHL RedHill Biopharma
$9.19 /

-0.33 (-3.47%)

11/12/20 Roth Capital
RedHill Biopharma price target lowered to $12 from $16 at Roth Capital
09/11/20 BTIG
RedHill Biopharma initiated with a Buy at BTIG
08/14/20 Roth Capital
Roth Capital maintains Buy on RedHill after 'noisy' quarter
07/07/20 SMBC Nikko
RedHill Biopharma initiated with an Outperform at SMBC Nikko
COHU Cohu
$46.01 /

+2.46 (+5.65%)

02/12/21 Craig-Hallum
Cohu price target raised to $73 from $45 at Craig-Hallum
02/12/21 B. Riley Securities
Cohu price target raised to $72 from $60 at B. Riley Securities
02/10/21 B. Riley Securities
B. Riley Securities sees interesting opportunities in Skyworks, Silicon Motion
01/25/21 B. Riley Securities
Cohu price target raised to $60 from $46 at B. Riley Securities
BYND Beyond Meat
$147.09 /

+1.7 (+1.17%)

03/01/21 DA Davidson
Beyond Meat price target raised to $145 from $133 at DA Davidson
02/26/21 Piper Sandler
Beyond Meat relationship with McDonald's not much changed, says Piper Sandler
02/26/21 UBS
Beyond Meat price target raised to $130 from $107 at UBS
02/26/21 Goldman Sachs
Beyond Meat price target raised to $112 from $105 at Goldman Sachs
ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

TTEC TTEC Holdings
$88.80 /

+4.49 (+5.33%)

TMDX TransMedics
$36.30 /

+0.33 (+0.92%)

SWCH Switch
$17.69 /

+0.33 (+1.90%)

SRPT Sarepta
$86.94 /

-0.07 (-0.08%)

SILK Silk Road Medical
$55.35 /

+0.53 (+0.97%)

SGMS Scientific Games
$50.79 /

+3.84 (+8.18%)

SCPL SciPlay
$19.28 /

+1.07 (+5.88%)

ROKU Roku
$420.23 /

+25.095 (+6.35%)

RDHL RedHill Biopharma
$9.19 /

-0.33 (-3.47%)

OSUR OraSure
$11.08 /

+0.42 (+3.94%)

NVAX Novavax
$239.73 /

+8.52 (+3.68%)

NLSN Nielsen
$23.15 /

+0.73 (+3.26%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

MREO Mereo BioPharma
$3.96 /

+0.07 (+1.80%)

MORF Morphic
$84.57 /

+48.64 (+135.37%)

MELI MercadoLibre
$1,715.90 /

+80.81 (+4.94%)

LMND Lemonade
$132.23 /

+6.5 (+5.17%)

INSG Inseego
$15.00 /

+0.35 (+2.39%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

HLIO Helios Technologies
$67.14 /

+1.295 (+1.97%)

FGEN FibroGen
$50.35 /

+0.38 (+0.76%)

COHU Cohu
$46.01 /

+2.46 (+5.65%)

BYND Beyond Meat
$147.09 /

+1.7 (+1.17%)

ASLN Aslan Pharmaceuticals
$5.22 /

+0.82 (+18.64%)

APPF AppFolio
$160.72 /

-4.985 (-3.01%)

AMRC Ameresco
$60.46 /

+3.18 (+5.55%)

AI C3.ai
$120.78 /

+8.41 (+7.48%)

  • 03
    Mar
  • 03
    Mar
  • 03
    Mar
  • 02
    Mar
  • 10
    Feb
  • 21
    Jan
  • 13
    Jan
  • 14
    Jan
  • 14
    Dec
  • 09
    Dec
  • 31
    Aug
  • 02
    Jul
  • 11
    Jun
  • 03
    Jun
  • 27
    May
  • 06
    May
  • 17
    Mar
ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

SGMS Scientific Games
$50.79 /

+3.84 (+8.18%)

ROKU Roku
$420.23 /

+25.095 (+6.35%)

NVAX Novavax
$239.73 /

+8.52 (+3.68%)

NLSN Nielsen
$23.15 /

+0.73 (+3.26%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

LMND Lemonade
$132.23 /

+6.5 (+5.17%)

INSG Inseego
$15.00 /

+0.35 (+2.39%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

BYND Beyond Meat
$147.09 /

+1.7 (+1.17%)

ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

SRPT Sarepta
$86.94 /

-0.07 (-0.08%)

SGMS Scientific Games
$50.79 /

+3.84 (+8.18%)

ROKU Roku
$420.23 /

+25.095 (+6.35%)

OSUR OraSure
$11.08 /

+0.42 (+3.94%)

NVAX Novavax
$239.73 /

+8.52 (+3.68%)

NLSN Nielsen
$23.15 /

+0.73 (+3.26%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

MORF Morphic
$84.57 /

+48.64 (+135.37%)

LMND Lemonade
$132.23 /

+6.5 (+5.17%)

INSG Inseego
$15.00 /

+0.35 (+2.39%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

FGEN FibroGen
$50.35 /

+0.38 (+0.76%)

COHU Cohu
$46.01 /

+2.46 (+5.65%)

BYND Beyond Meat
$147.09 /

+1.7 (+1.17%)

AI C3.ai
$120.78 /

+8.41 (+7.48%)

ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

TMDX TransMedics
$36.30 /

+0.33 (+0.92%)

ROKU Roku
$420.23 /

+25.095 (+6.35%)

OSUR OraSure
$11.08 /

+0.42 (+3.94%)

NVAX Novavax
$239.73 /

+8.52 (+3.68%)

NLSN Nielsen
$23.15 /

+0.73 (+3.26%)

NIO NIO
$49.79 /

+3.08 (+6.59%)

LMND Lemonade
$132.23 /

+6.5 (+5.17%)

INSG Inseego
$15.00 /

+0.35 (+2.39%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

FGEN FibroGen
$50.35 /

+0.38 (+0.76%)

BYND Beyond Meat
$147.09 /

+1.7 (+1.17%)

AI C3.ai
$120.78 /

+8.41 (+7.48%)

Hot Stocks
TransMedics announces scheduling of OCS Heart FDA AdCom meeting » 18:54
03/01/21
03/01
18:54
03/01/21
18:54
TMDX

TransMedics

$36.30 /

+0.33 (+0.92%)

TransMedics Group…

TransMedics Group announced that the FDA's Office of Health Technology 2 has communicated its intent to hold a Circulatory Systems Device Advisory Panel meeting on April 6, 2021 to review TransMedics' premarket approval application for the OCS Heart System. "We are looking forward to this important milestone and to hopefully achieving a positive conclusion of the FDA's review process of our OCS Heart PMA application," said Waleed Hassanein, M.D., CEO.

ShowHide Related Items >><<
TMDX TransMedics
$36.30 /

+0.33 (+0.92%)

TMDX TransMedics
$36.30 /

+0.33 (+0.92%)

02/24/21 Cowen
TransMedics price target raised to $44 from $20 at Cowen
10/08/20
Fly Intel: Top five analyst downgrades
10/08/20 JPMorgan
TransMedics downgraded to Neutral on 'missed' execution at JPMorgan
10/08/20 JPMorgan
TransMedics downgraded to Neutral from Overweight at JPMorgan
TMDX TransMedics
$36.30 /

+0.33 (+0.92%)

  • 27
    May
TMDX TransMedics
$36.30 /

+0.33 (+0.92%)

Initiation
TechnipFMC initiated with a Neutral at Exane BNP Paribas » 18:48
03/01/21
03/01
18:48
03/01/21
18:48
FTI

TechnipFMC

$8.42 /

+0.195 (+2.37%)

Exane BNP Paribas analyst…

Exane BNP Paribas analyst Nick Konstantakis initiated coverage of TechnipFMC with a Neutral rating and EUR 7 price target. The analyst notes the company's "milestone" of completing the spinoff of Technip Energies, with attention now turning to its 2021 guidance "surprising positively" on its Subsea margin. Konstantakis adds however that 2021 will be the year that TechnipFMC will need to demonstrate that it can thrive as a stand-alone entity, with the company's free cash flows having lagged its peer group.

ShowHide Related Items >><<
FTI TechnipFMC
$8.42 /

+0.195 (+2.37%)

FTI TechnipFMC
$8.42 /

+0.195 (+2.37%)

03/01/21 Exane BNP Paribas
Technip Energies initiated with a Neutral at Exane BNP Paribas
03/01/21
Fly Intel: Top five analyst downgrades
03/01/21 Morgan Stanley
TechnipFMC downgraded to Equal Weight at Morgan Stanley
03/01/21 Morgan Stanley
TechnipFMC downgraded to Equal Weight from Overweight at Morgan Stanley
FTI TechnipFMC
$8.42 /

+0.195 (+2.37%)

FTI TechnipFMC
$8.42 /

+0.195 (+2.37%)

FTI TechnipFMC
$8.42 /

+0.195 (+2.37%)

FTI TechnipFMC
$8.42 /

+0.195 (+2.37%)

Hot Stocks
SailPoint CEO: We have a very strong position in the market » 18:44
03/01/21
03/01
18:44
03/01/21
18:44
SAIL

SailPoint

$60.43 /

+4.04 (+7.16%)

In an interview on…

In an interview on CNBC's Mad Money, Mark McClain said transformation from legacy systems is driving business to the company. "We're trying to give customers a multi-layer level of security," McClain said.

ShowHide Related Items >><<
SAIL SailPoint
$60.43 /

+4.04 (+7.16%)

SAIL SailPoint
$60.43 /

+4.04 (+7.16%)

03/01/21 Needham
SailPoint upgraded to Buy from Hold at Needham
03/01/21 Morgan Stanley
SailPoint price target raised to $75 from $71 at Morgan Stanley
02/16/21 Canaccord
SailPoint price target raised to $70 from $53 at Canaccord
01/27/21 RBC Capital
SailPoint price target raised to $68 from $55 at RBC Capital
SAIL SailPoint
$60.43 /

+4.04 (+7.16%)

SAIL SailPoint
$60.43 /

+4.04 (+7.16%)

Initiation
Technip Energies initiated with a Neutral at Exane BNP Paribas » 18:44
03/01/21
03/01
18:44
03/01/21
18:44
THNPF

Technip Energies

$0.00 /

+ (+0.00%)

, FTI

TechnipFMC

$8.42 /

+0.195 (+2.37%)

Exane BNP Paribas analyst…

Exane BNP Paribas analyst Nick Konstantakis initiated coverage of Technip Energies (THNPF) with a Neutral rating and EUR 10.7 price target. The analyst is positive on the company's position as a "differentiated" name with "prime" LNG and Petrochemical exposure, and he sees "significant opportunities" for Technip to secure major awards in the near term. Konstantakis adds however that the potential overhang from TechnipFMC's (FTI) stake and "share flowback" is an overhang risk.

ShowHide Related Items >><<
FTI TechnipFMC
$8.42 /

+0.195 (+2.37%)

THNPF Technip Energies
$0.00 /

+ (+0.00%)

03/01/21 Morgan Stanley
Technip Energies initiated with an Overweight at Morgan Stanley
02/22/21 Barclays
Technip Energies initiated with an Equal Weight at Barclays
FTI TechnipFMC
$8.42 /

+0.195 (+2.37%)

03/01/21
Fly Intel: Top five analyst downgrades
03/01/21 Morgan Stanley
TechnipFMC downgraded to Equal Weight at Morgan Stanley
03/01/21 Morgan Stanley
TechnipFMC downgraded to Equal Weight from Overweight at Morgan Stanley
02/22/21 Barclays
TechnipFMC downgraded to Equal Weight from Overweight at Barclays
FTI TechnipFMC
$8.42 /

+0.195 (+2.37%)

FTI TechnipFMC
$8.42 /

+0.195 (+2.37%)

FTI TechnipFMC
$8.42 /

+0.195 (+2.37%)

FTI TechnipFMC
$8.42 /

+0.195 (+2.37%)

Hot Stocks
Ready Capital declares 30c per share prorated dividend » 18:36
03/01/21
03/01
18:36
03/01/21
18:36
RC

Ready Capital

$13.39 /

+0.28 (+2.14%)

Ready Capital announced…

Ready Capital announced that its board of directors declared a prorated dividend of 30c per share of common stock and operating partnership unit. The Prorated Dividend is payable on March 18 to common stockholders and operating partnership unitholders of record as of the close of business on March 15. The Prorated Dividend was declared by the board of directors in accordance with the Agreement and Plan of Merger, dated as of December 6, 2020, by and among Ready Capital, RC Merger Subsidiary, LLC and Anworth Mortgage Asset Corporation relating to the previously announced merger of Ready Capital and Anworth.

ShowHide Related Items >><<
RC Ready Capital
$13.39 /

+0.28 (+2.14%)

RC Ready Capital
$13.39 /

+0.28 (+2.14%)

02/02/21 BTIG
Ready Capital initiated with a Buy at BTIG
11/24/20 B. Riley Securities
Ready Capital price target raised to $14.50 from $12 at B. Riley Securities
09/25/20 B. Riley Securities
Ready Capital price target raised to $12 from $11 at B. Riley FBR
08/07/20 Ladenburg
Ready Capital upgraded to Buy from Neutral at Ladenburg
RC Ready Capital
$13.39 /

+0.28 (+2.14%)

Hot Stocks
Genetic Technologies trading halted, news pending  18:25
03/01/21
03/01
18:25
03/01/21
18:25
GENE

Genetic Technologies

$4.41 /

+0.06 (+1.38%)

 
ShowHide Related Items >><<
GENE Genetic Technologies
$4.41 /

+0.06 (+1.38%)

GENE Genetic Technologies
$4.41 /

+0.06 (+1.38%)

Conference/Events
Jefferies analyst to hold analyst/industry conference call » 18:25
03/01/21
03/01
18:25
03/01/21
18:25

Analyst Thanh Ha Pham,…

Analyst Thanh Ha Pham, along with Joe Holman, Founder of ESG Administration, discuss ESG integration and carbon accounting on an Analyst/Industry conference call to be held on March 1 at 7 pm.

Hot Stocks
TTEC Holdings raises semi-annual dividend by 7.5% to 43c per share » 18:11
03/01/21
03/01
18:11
03/01/21
18:11
TTEC

TTEC Holdings

$88.80 /

+4.49 (+5.33%)

The dividend is payable…

The dividend is payable on April 21, 2021 to shareholders of record as of April 5, 2021.

ShowHide Related Items >><<
TTEC TTEC Holdings
$88.80 /

+4.49 (+5.33%)

TTEC TTEC Holdings
$88.80 /

+4.49 (+5.33%)

12/17/20 Canaccord
TTEC Holdings price target raised to $90 from $77 at Canaccord
10/15/20 Canaccord
TTEC Holdings model steadily shifts to digital, Canaccord starts with a Buy
10/15/20 Canaccord
TTEC Holdings initiated with a Buy at Canaccord
08/10/20
Fly Intel: Top five analyst downgrades
TTEC TTEC Holdings
$88.80 /

+4.49 (+5.33%)

Periodicals
New EU 'Right to Repair' rules require goods to be repairable, Independent says » 18:10
03/01/21
03/01
18:10
03/01/21
18:10
AAPL

Apple

$127.79 /

+6.54 (+5.39%)

Legislation from the…

Legislation from the European Parliament, which recently backed sturdier "right to repair" rules, for companies that sell consumer electronics "in the European Union - and in the UK," that will require manufacturers guaranty that goods can be repaired for up to 10 years, wrote the Independent's Adam Smith. In the future environmentalists and consumer rights groups want smartphones, laptops and other small electrical devices to be included in the "right to repair" rules, noted the story. "Apple last year announced it would start providing training and spare parts to certified independent repair stores fixing Mac computers, not just iPhones," added the Independent story. Reference Link

ShowHide Related Items >><<
AAPL Apple
$127.79 /

+6.54 (+5.39%)

AAPL Apple
$127.79 /

+6.54 (+5.39%)

03/01/21 Wedbush
Asia checks bullish for Apple iPhone 12 builds, says Wedbush
03/01/21 JPMorgan
Broadcom won new new wireless charging chipset in iPhone 13, says JPMorgan
02/25/21 JPMorgan
JPMorgan 'tweaks' EPS estimate for Apple after cut to iPhone forecasts
02/24/21 Piper Sandler
Piper sees Apple developing 'full-blown' branded electric vehicle
AAPL Apple
$127.79 /

+6.54 (+5.39%)

AAPL Apple
$127.79 /

+6.54 (+5.39%)

AAPL Apple
$127.79 /

+6.54 (+5.39%)

AAPL Apple
$127.79 /

+6.54 (+5.39%)

Recommendations
Astec price target raised to $92 from $90 at Baird » 18:08
03/01/21
03/01
18:08
03/01/21
18:08
ASTE

Astec

$72.08 /

+4.07 (+5.98%)

Baird analyst Mircea…

Baird analyst Mircea Dobre raised the firm's price target on Astec to $92 from $90 and keeps an Outperform rating on the shares. The company's 2020 demonstrated the management's ability to "effectively" cut costs and consolidate operations to address internal control deficiencies, the analyst tells investors in a research note. Dobre adds that Astec also highlighted strong customer backlogs being supported by increased Federal funding, along with over 25 individual state initiatives aimed at "driving higher infrastructure investment".

ShowHide Related Items >><<
ASTE Astec
$72.08 /

+4.07 (+5.98%)

ASTE Astec
$72.08 /

+4.07 (+5.98%)

03/01/21 Baird
Astec order rebound frames growth potential for 2021, says Baird
12/30/20 Sidoti
Astec price target raised to $64 from $58 at Sidoti
12/15/20 Stifel
Astec price target raised to $62 from $55 at Stifel
12/11/20 Baird
Astec price target raised to $71 from $47 at Baird
ASTE Astec
$72.08 /

+4.07 (+5.98%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.